c7ÓéÀÖ¹Ù·½Èë¿Ú

¡¡¡¡½üÆÚ£¬c7ÓéÀÖ¹Ù·½Èë¿ÚÈ¡µÃ¶àÏî¿ÆÑÐÐÂÍ»ÆÆ£¬Ë¶¹ûÀÛÀÛ£¬³É¾ÍÆÄ·á¡£ÌØÑ¡²¿·ÖÖصã¿ÆÑгɹûËÙÀÀ»Ø¹Ë¡£

c7ÓéÀÖ¹Ù·½Èë¿ÚÒ½¹¤Ð­×÷ÍŶÓÔÚÈ«ÉíÂé×íÒ©Îï¼õ¶¾ÔöЧ·½ÃæÈ¡µÃÖØÒª½øÕ¹

¡¡

¡¡¡¡½üÈÕ£¬c7ÓéÀÖ¹Ù·½Èë¿ÚÉúÃü¿ÆѧÓë¼¼Êõc7ÓéÀÖ¹Ù·½Èë¿Ú²©Ê¿ÉúÕÅ˸ΪµÚÒ»×÷Õߣ¬ÉúÃü¿ÆѧÓë¼¼Êõc7ÓéÀÖ¹Ù·½Èë¿ÚÎâµÀ³Î½ÌÊں͵ÚÒ»¸½ÊôÒ½ÔºÂé×íÊÖÊõ²¿¸±Ö÷ÈθßΡ¸±Ö÷ÈÎҽʦΪ¹²Í¬Í¨Ñ¶×÷Õߣ¬ÔÚÖøÃûÆÚ¿¯¡¶¾Û¼¯Ìå¡·£¨Aggregate, IF=18.8£©ÉÏÔÚÏß·¢±íÒÔÌâΪ¡¶³¬ÉùÁªºÏѪÄÔÆÁÕÏ°ÐÏò·Ö×ÓµÝËÍËĺÏÒ»·Ö×Ó¾Û¼¯ÌåÈëÄÔͨ¹ýÒì±û·Ó-ÒÀÍÐßäõ¥Ð­Í¬ÒÖÖÆGABAÊÜÌåÀ´ÔöÇ¿Âé×íЧ¹û²¢½µµÍ¶¾ÐÔ¡·µÄÑо¿ÂÛÎÄ¡£¸Ã¹¤×÷µÃµ½Á˹ú¼Ò×ÔÈ»¿Æѧ»ù½ð¡¢ÉÂÎ÷Ê¡¡°¸ß²ã´ÎÈ˲ÅרÏîÖ§³Ö¼Æ»®¡±ÇàÄê°Î¼âÈ˲ÅÏîÄ¿µÄ×ÊÖú¡£c7ÓéÀÖ¹Ù·½Èë¿Ú·ÖÎö²âÊÔÖÐÐĺÍÉúÎïҽѧʵÑéÖÐÐÄΪ±¾¹¤×÷ÌṩÁË´óÁ¿Ñо¿Ö§³Ö¡£

µÚÒ»¸½ÊôÒ½ÔººÎÍúæç¿ÆÑÐÍŶÓÔÚÖ×ÁöÃâÒßÖÎÁÆ΢µ°°×Ò©ÎïÉè¼Æ·½Ãæ±³¿¿±³·¢±íÑо¿³É¹û

¡¡¡¡c7ÓéÀÖ¹Ù·½Èë¿ÚµÚÒ»¸½ÊôÒ½ÔººÎÍúæçÑо¿Ô±ÎªÎÄÕÂͨѶ×÷Õߣ¬Ö×ÁöÄڿƽ¯°®Ãñ²©Ê¿Îª±¾ÎĵÚÒ»×÷Õߣ¬ÔÚÖøÃûÆÚ¿¯¡¶ACS Nano¡·£¨IF=17.1£©ÉÏ·¢±íÌâΪ¡°Advancing the boundaries of immunotherapy in lung adenocarcinoma with idiopathic pulmonary fibrosis by a biomimetic proteinoid enabling selective endocytosis¡±µÄ¿ÆÑÐÂÛÎÄ¡£

µÚÒ»¸½ÊôÒ½ÔºÖ×Áö·ÅÁÆ¿ÆÕÔ¶«Àû½ÌÊÚÍŶÓÔÚ¡¶ÁøÒ¶µ¶¡·Õý¿¯·¢±íÖØÒªÑо¿ÆÀÊöÎÄÕÂ

¡¡¡¡µÚÒ»×÷ÕßÕÔ¶«Àû½ÌÊÚ¡¢Í¨Ñ¶×÷Õß·ӽ¿­ÎïÀíʦ£¨¹²Í¬×÷ÕßÀîÒã¸ß¼¶¹¤³Ìʦ¡¢ÇúÒÔƽÖ÷ÖÎҽʦºÍºÎ³¿è¡Ö÷ÖÎҽʦ£©ÔÚ¡¶ÁøÒ¶µ¶¡·£¨IF=168.9£©ÉϵÄcorrespondenceרÀ¸ÉÏ·¢±íÒÔ¡°Challenges for breast radiotherapy with SIB: the IMPORT HIGH trial£¨SIBÈéÏÙ·ÅÉäÖÎÁÆÃæÁÙµÄÌôÕ½£ºIMPORT HIGHÊÔÑ飩¡±ÎªÌâµÄÎÄÕ¡£

»ù´¡Ò½c7ÓéÀÖ¹Ù·½Èë¿ÚÍŶÓÑо¿·¢±íÖáÍ»ÄÒÅÝɸѡлúÖÆ

¡¡¡¡c7ÓéÀÖ¹Ù·½Èë¿Ú»ù´¡Ò½c7ÓéÀÖ¹Ù·½Èë¿ÚÑîÌÊÚ£¬ÍŶӳÉÔ±²©Ê¿ºóº«ÔÀ¡¢ÁõÕÜ£¬²©Ê¿ÉúÀîÃô£¬Ñо¿ÉúÕÔ±ùÇå¡¢ÁõÑà¡¢Íõ»Û³¬£¬ÔÚ¡¶ÃÀ¹ú¿Æc7ÓéÀÖ¹Ù·½Èë¿ÚÔº¿¯¡·(PNAS)ÉÏ·¢±íÌâΪ¡¶MARK2Á×ËữKIF13AµÄ14-3-3½áºÏλµãµ÷¿ØתÌúµ°°×ÊÜÌåÄÒÅÝÔÚÊ÷Í»Éϵļ«»¯×ªÔË¡·£¨MARK2 phosphorylates KIF13A at a 14-3-3 binding site to polarize vesicular transport of transferrin receptor within dendrites£©µÄ¿ÆÑÐÎÄÕ¡£¸ÃÑо¿ÎªÖáÍ»ÎïÖʵÄÑ¡ÔñÐÔתÔËÌṩÁËÒ»¸öеÄÊӽǣ¬¼´ÄÒÅݵļ«ÐÔתÔË¿ÉÄÜÓëÖáÍ»ÆðʼÇøÓò¸»¼¯µÄµ°°×¼¤Ã¸µ÷¿ØÏà¹Ø¡£

Ò©c7ÓéÀÖ¹Ù·½Èë¿ÚÕÅÑåÃñ½ÌÊÚÁªºÏ»¯¹¤c7ÓéÀÖ¹Ù·½Èë¿Ú³ÂöνÌÊÚ¡¢Äܶ¯c7ÓéÀÖ¹Ù·½Èë¿ÚÁõº£ºþ½ÌÊÚ

¹¹½¨»ùÓÚÉúÀíÏìÓ¦¼°µ÷¿ØÐÍÄÉÃ×½ð´ØµÄ¾«×¼¿ÉÊÓ¶ñÐÔÖ×ÁöÖÎÁÆ

¡¡¡¡c7ÓéÀÖ¹Ù·½Èë¿ÚÒ©c7ÓéÀÖ¹Ù·½Èë¿ÚÕÅÑåÃñ½ÌÊÚ¡¢»¯¹¤c7ÓéÀÖ¹Ù·½Èë¿Ú³ÂöνÌÊÚ¡¢Äܶ¯c7ÓéÀÖ¹Ù·½Èë¿ÚÁõº£ºþ½ÌÊÚΪÂÛÎĵÄͨѶ×÷Õߣ¬²©Ê¿ÉúÁõ·ã¡¢ÑîÌì·ãºÍ³£Ð¡ÎÀΪ¹²Í¬µÚÒ»×÷Õߣ¬ÔÚ¡¶¹ú¼Ò¿ÆѧÆÀÂÛ¡·£¨National Science Review£©·¢±íÌâΪ¡°Intelligent gold nanocluster for effective treatment of malignant tumor via tumor-specific photothermal-chemodynamic therapy with AIE guidance¡±µÄ¿ÆÑÐÂÛÎÄ¡£¸ÃÂÛÎĵõ½Á˹ú¼Ò¸ß²ã´ÎÈ˲ÅÌØÊâÖ§³Ö¼Æ»®¡¢¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð¡¢ÉÂÎ÷Ê¡×ÔÈ»¿Æѧ»ù½ð¡¢c7ÓéÀÖ¹Ù·½Èë¿Ú¡°ÇàÄê°Î¼âÈ˲ÅÖ§³Ö¼Æ»®¡±µÈÏîÄ¿µÄ´óÁ¦Ö§³Ö¡£